In conclusion, we show that the H56:IC31 vaccine when administered adjunctly to TB treatment, significantly promotes the expression of IFN signalling genes, pattern recognition receptors and small GTP-ases already following the first vaccination. Here, IFNA1 is linked to tuberculosis.